GLP-1 receptor agonists, of which semaglutide (a.k.a. Ozempic) is the most well known example, has revolutionized obesity management. Though cost was a limiting factor for many, for others the idea of injecting themselves weekly was a non-starter. But for those afraid of needles, the last few months have shown that oral versions of these medications may offer a real alternative.

There with you then. Here with you now. As a critical part of the community for over 245 years,The Gazette continues to deliver trusted English-language news and coverage on issues that matter. Subscribe now to receive:

There with you then. Here with you now. As a critical part of the community for over 245 years,The Gazette continues to deliver trusted English-language news and coverage on issues that matter. Subscribe now to receive:

There with you then. Here with you now. As a critical part of the community for over 245 years,The Gazette continues to deliver trusted English-language news and coverage on issues that matter. Create an account or sign in to continue with your reading experience.

Create an account or sign in to continue with your reading experience.

Oral semaglutide is not new. From its inception, Novo........

© Montreal Gazette